{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:13:03Z","timestamp":1793045583182,"version":"4.5.0"},"reference-count":70,"publisher":"BMJ","issue":"2","funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2015514, 2016627"],"award-info":[{"award-number":["2015514, 2016627"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Sex Reprod Health"],"accepted":{"date-parts":[[2024,1,28]]},"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec>\n                  <jats:title>Objective and rationale<\/jats:title>\n                  <jats:p>To identify and appraise current national and international clinical menopause guidance documents, and to extract and compare the recommendations of the most robust examples.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Systematic review.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Data sources<\/jats:title>\n                  <jats:p>Ovid MEDLINE, EMBASE, PsycINFO and Web of Science<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Eligibility criteria for selecting studies<\/jats:title>\n                  <jats:p>Practice guidance documents for menopause published from 2015 until 20 July 2023. Quality was assessed by the Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Twenty-six guidance papers were identified. Of these, five clinical practice guidelines (CPGs) and one non-hormonal therapy position statement met AGREE II criteria of being at least of moderate quality. The five CPGs listed symptoms associated with the perimenopause and menopause to be vasomotor symptoms (VMS), disturbed sleep, musculoskeletal pain, decreased sexual function or desire, and mood disturbance (low mood, mood changes or depressive symptoms). Acknowledged potential long-term menopause consequences were urogenital atrophy, and increased risks of cardiovascular disease and osteoporosis. VMS and menopause-associated mood disturbance were the only consistent indications for systemic menopausal hormone therapy (MHT). Some CPGs supported MHT to prevent or treat osteoporosis, but specific guidance was lacking. None recommended MHT for cognitive symptoms or prevention of other chronic disease. Perimenopause-specific recommendations were scant. A neurokinin 3B antagonist, selective serotonin\/norepinephrine (noradrenaline) reuptake inhibitors and gabapentin were recommended non-hormonal medications for VMS, and cognitive behavioural therapy and hypnosis were consistently considered as being of potential benefit.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>The highest quality CPGs consistently recommended MHT for VMS and menopause-associated mood disturbance, whereas clinical depression or cognitive symptoms, and cardiometabolic disease and dementia prevention were not treatment indications. Further research is needed to inform clinical recommendations for symptomatic perimenopausal women.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjsrh-2023-202099","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T21:20:36Z","timestamp":1707513636000},"page":"122-138","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":38,"title":["A systematic review and critical appraisal of menopause guidelines"],"prefix":"10.1136","volume":"50","author":[{"given":"Chandima","family":"Hemachandra","sequence":"first","affiliation":[{"name":"Women's Health Research Program, Monash University School of Public Health and Preventive Medicine, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha","family":"Taylor","sequence":"additional","affiliation":[{"name":"Women's Health Research Program, Monash University School of Public Health and Preventive Medicine, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakibul M","family":"Islam","sequence":"additional","affiliation":[{"name":"Women's Health Research Program, Monash University School of Public Health and Preventive Medicine, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ensieh","family":"Fooladi","sequence":"additional","affiliation":[{"name":"Monash School of Nursing and Midwifery, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2955-0415","authenticated-orcid":false,"given":"Susan R","family":"Davis","sequence":"additional","affiliation":[{"name":"Women's Health Research Program, Monash University School of Public Health and Preventive Medicine, Melbourne, Victoria, Australia"},{"name":"Endocrinology and Diabetes, Alfred Health, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,2,9]]},"reference":[{"key":"2025090510440365000_50.2.122.1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.180"},{"key":"2025090510440365000_50.2.122.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1514242"},{"key":"2025090510440365000_50.2.122.3","doi-asserted-by":"crossref","unstructured":"Harper JC , Phillips S , Biswakarma R , et al . An online survey of perimenopausal women to determine their attitudes and knowledge of the menopause. Womens Health (Lond) 2022;18. doi:10.1177\/17455057221106890","DOI":"10.1177\/17455057221106890"},{"key":"2025090510440365000_50.2.122.4","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/GME.0000000000001282","article-title":"Menopausal hormone therapy trends before versus after 2002: impact of the Women\u2019s Health Initiative Study Results","volume":"26","author":"Crawford","year":"2019","journal-title":"Menopause"},{"key":"2025090510440365000_50.2.122.5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.1.47"},{"key":"2025090510440365000_50.2.122.6","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2021.1936486"},{"key":"2025090510440365000_50.2.122.7","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e31813429d6"},{"key":"2025090510440365000_50.2.122.8","unstructured":"National Health Service (NHS) . Hormone replacement therapy \u2013 England. NHS Business Services Authority; 2015. Available: https:\/\/www.nhsbsa.nhs.uk\/statistical-collections\/hormone-replacement-therapy-england\/hormone-replacement-therapy-england-april-2015-june-2022#:~:text=In%20England%20in%202021%2F22,1.48%20million%20in%202020%2F21"},{"key":"2025090510440365000_50.2.122.9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.maturitas.2023.02.006","article-title":"Menopause and social media: pros and cons for the general public","volume":"174","author":"Weiss","year":"2023","journal-title":"Maturitas"},{"key":"2025090510440365000_50.2.122.10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/20533691211038780","article-title":"Learning from celebrities and influencers - The future of menopause communication?","volume":"27","author":"Morris","year":"2021","journal-title":"Post Reprod Health"},{"key":"2025090510440365000_50.2.122.11","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2014.4746"},{"key":"2025090510440365000_50.2.122.12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/20533691231166543","article-title":"An online survey of postmenopausal women to determine their attitudes and knowledge of the menopause","volume":"29","author":"Aljumah","year":"2023","journal-title":"Post Reprod Health"},{"key":"2025090510440365000_50.2.122.13","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1213\/ANE.0000000000004236","article-title":"Consistent definitions of clinical practice guidelines, consensus statements, position statements, and practice alerts","volume":"129","author":"Joshi","year":"2019","journal-title":"Anesth Analg"},{"key":"2025090510440365000_50.2.122.14","unstructured":"Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines . Clinical practice guidelines we can trust. Washington DC: National Academies Press (US), 2011. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK209539\/"},{"key":"2025090510440365000_50.2.122.15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7182.527"},{"key":"2025090510440365000_50.2.122.16","unstructured":"Davies J , Freemantle N , Grimshaw J , et al . Implementing clinical practice guidelines. Can guidelines be used to improve practice? Effective health care bulletin. UK University of Leeds; 1994. 8."},{"key":"2025090510440365000_50.2.122.17","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2014.929651"},{"key":"2025090510440365000_50.2.122.18","doi-asserted-by":"crossref","unstructured":"Page MJ , McKenzie JE , Bossuyt PM , et al . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372. doi:10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"2025090510440365000_50.2.122.19","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.090449"},{"key":"2025090510440365000_50.2.122.20","doi-asserted-by":"publisher","DOI":"10.1037\/\/1040-3590.6.4.284"},{"key":"2025090510440365000_50.2.122.21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s13244-017-0563-4","article-title":"A critical appraisal of the quality of adult musculoskeletal ultrasound guidelines using the AGREE II tool: an EuroAIM initiative","volume":"8","author":"Messina","year":"2017","journal-title":"Insights Imaging"},{"key":"2025090510440365000_50.2.122.22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.maturitas.2019.09.009","article-title":"Menopause guideline appraisal and algorithm development for premature ovarian insufficiency","volume":"130","author":"Yeganeh","year":"2019","journal-title":"Maturitas"},{"key":"2025090510440365000_50.2.122.23","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1055\/a-1361-1948","article-title":"Perimenopause and Postmenopause - Diagnosis and Interventions. Guideline of the DGGG and OEGGG (S3-Level, AWMF Registry Number 015-062, September 2020)","volume":"81","author":"Inwald","year":"2021","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"2025090510440365000_50.2.122.24","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00404-020-05682-4","article-title":"Peri- and postmenopause-diagnosis and interventions interdisciplinary S3 guideline of the association of the scientific medical societies in Germany (AWMF 015\/062): short version","volume":"302","author":"Ortmann","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"2025090510440365000_50.2.122.25","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2015.1129166"},{"key":"2025090510440365000_50.2.122.26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.maturitas.2016.06.001","article-title":"Revised global consensus statement on menopausal hormone therapy","volume":"91","author":"de Villiers","year":"2016","journal-title":"Maturitas"},{"key":"2025090510440365000_50.2.122.27","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000002200"},{"key":"2025090510440365000_50.2.122.28","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000002028"},{"key":"2025090510440365000_50.2.122.29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.maturitas.2022.04.008","article-title":"Menopause, wellbeing and health: a care pathway from the European Menopause and Andropause Society","volume":"163","author":"Lambrinoudaki","year":"2022","journal-title":"Maturitas"},{"key":"2025090510440365000_50.2.122.30","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.maturitas.2015.04.009","article-title":"EMAS position statement: non-hormonal management of menopausal vasomotor symptoms","volume":"81","author":"Mintziori","year":"2015","journal-title":"Maturitas"},{"key":"2025090510440365000_50.2.122.31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.maturitas.2015.02.003","article-title":"EMAS position statement: the ten point guide to the integral management of menopausal health","volume":"81","author":"Neves-e-Castro","year":"2015","journal-title":"Maturitas"},{"key":"2025090510440365000_50.2.122.32","unstructured":"National Institute for Health and Care Excellence (NICE), National Collaborating Centre for Women\u2019s and Children\u2019s Health (NCC-WCH) . Menopause: full guideline; 2015. Available: https:\/\/www.nice.org.uk\/guidance\/ng23\/evidence\/fullguideline-559549261"},{"key":"2025090510440365000_50.2.122.33","doi-asserted-by":"publisher","DOI":"10.6118\/jmm.20000"},{"key":"2025090510440365000_50.2.122.34","first-page":"230","article-title":"AEEM-SEGO position statement on menopausal hormone therapy","volume":"61","author":"Borrego","year":"2018","journal-title":"Progresos de Obstetricia y Ginecologia"},{"key":"2025090510440365000_50.2.122.35","first-page":"395","article-title":"Recommendations on menopausal hormone replacement therapy","volume":"71","author":"Cagnacci","year":"2019","journal-title":"Minerva Ginecol"},{"key":"2025090510440365000_50.2.122.36","doi-asserted-by":"publisher","DOI":"10.1177\/2053369120957514"},{"key":"2025090510440365000_50.2.122.37","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/jog.13684","article-title":"Japan Society of Obstetrics and Gynecology and Japan Society for Menopause and Women\u2019s Health 2017 guidelines for hormone replacement therapy","volume":"44","author":"Okano","year":"2018","journal-title":"J Obstet Gynaecol Res"},{"key":"2025090510440365000_50.2.122.38","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2236"},{"key":"2025090510440365000_50.2.122.39","unstructured":"Meeta DL , Agarwal N , Vaze N , et al . Clinical Practice Guideline on Menopause. 2nd ed. India: Indian Menopause Society, 2020."},{"key":"2025090510440365000_50.2.122.40","unstructured":"Obstetrical and Gynaecological Society of Malaysia (OGSM), Malaysian Menopause Society (MMS) . Clinical practice guidelines: management of Menopause in Malaysia; 2022. Available: https:\/\/www.moh.gov.my\/moh\/resources\/Penerbitan\/CPG\/Women%20Health\/CPG_Management_of_Menopause_2022_e-version-1.pdf"},{"key":"2025090510440365000_50.2.122.41","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.maturitas.2022.05.008","article-title":"Management of postmenopausal women: Coll\u00e8ge National des Gyn\u00e9cologues et Obst\u00e9triciens Fran\u00e7ais (CNGOF) and Groupe d\u2019Etude sur la M\u00e9nopause et le Vieillissement (GEMVi) Clinical Practice Guidelines","volume":"163","author":"Tr\u00e9mollieres","year":"2022","journal-title":"Maturitas"},{"key":"2025090510440365000_50.2.122.42","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.jogc.2021.08.003","article-title":"Guideline No. 422a: Menopause: vasomotor symptoms, prescription therapeutic agents, complementary and alternative medicine, nutrition, and lifestyle","volume":"43","author":"Yuksel","year":"2021","journal-title":"J Obstet Gynaecol Can"},{"key":"2025090510440365000_50.2.122.43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/20533691221104879","article-title":"Joint position statement by the British Menopause Society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology on best practice recommendations for the care of women experiencing the menopause","volume":"28","author":"Hamoda","year":"2022","journal-title":"Post Reprod Health"},{"key":"2025090510440365000_50.2.122.44","doi-asserted-by":"crossref","first-page":"345","DOI":"10.23736\/S0026-4784.19.04469-1","article-title":"Joint recommendations for the diagnosis and treatment of vulvo-vaginal atrophy in women in the peri- and post-menopausal phases from the Societ\u00e0 Italiana per la Menopausa (SIM) and the Societ\u00e0 Italiana della Terza Et\u00e0 (SIGiTE)","volume":"71","author":"Cagnacci","year":"2019","journal-title":"Minerva Ginecol"},{"key":"2025090510440365000_50.2.122.45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.maturitas.2021.04.005","article-title":"Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: an EMAS clinical guide","volume":"148","author":"Hirschberg","year":"2021","journal-title":"Maturitas"},{"key":"2025090510440365000_50.2.122.46","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jogc.2021.09.001","article-title":"Guideline No. 422b: Menopause and genitourinary health","volume":"43","author":"Johnston","year":"2021","journal-title":"J Obstet Gynaecol Can"},{"key":"2025090510440365000_50.2.122.47","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000001609"},{"key":"2025090510440365000_50.2.122.48","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1080\/09513590.2021.1943346","article-title":"Management of postmenopausal vulvovaginal atrophy: recommendations of the International Society for the Study of Vulvovaginal Disease","volume":"37","author":"P\u00e9rez-L\u00f3pez","year":"2021","journal-title":"Gynecol Endocrinol"},{"key":"2025090510440365000_50.2.122.49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/20533691211065808","article-title":"Consensus statement \u2013 Urogenital atrophy","volume":"28","author":"Briggs","year":"2022","journal-title":"Post Reprod Health"},{"key":"2025090510440365000_50.2.122.50","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.fertnstert.2012.05.051","article-title":"A decade after the Women\u2019s Health Initiative--the experts do agree","volume":"98","author":"Stuenkel","year":"2012","journal-title":"Fertil Steril"},{"key":"2025090510440365000_50.2.122.51","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.11217"},{"key":"2025090510440365000_50.2.122.52","doi-asserted-by":"crossref","unstructured":"Vinogradova Y , Coupland C , Hippisley-Cox J . Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ 2019;364. doi:10.1136\/bmj.k4810","DOI":"10.1136\/bmj.k4810"},{"key":"2025090510440365000_50.2.122.53","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1478-4505-4-28","article-title":"Improving the use of research evidence in guideline development: 16. Evaluation","volume":"4","author":"Oxman","year":"2006","journal-title":"Health Res Policy Sys"},{"key":"2025090510440365000_50.2.122.54","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-022-02539-9","article-title":"Quality assessment of Clinical Practice Guidelines (CPG) for the diagnosis and treatment of inflammatory bowel disease using the AGREE II instrument: a systematic review","volume":"22","author":"Zambrano-S\u00e1nchez","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"2025090510440365000_50.2.122.55","doi-asserted-by":"crossref","DOI":"10.3390\/healthcare4030036","article-title":"Barriers and strategies in guideline implementation-a scoping review","volume":"4","author":"Fischer","year":"2016","journal-title":"Healthcare (Basel)"},{"key":"2025090510440365000_50.2.122.56","unstructured":"Muir K . \u201cMission menopause: \"My hormones went off a cliff \u2013 and I'm not going to be ashamed\u201d The Guardian 2021. Available: https:\/\/www.theguardian.com\/society\/2021\/may\/09\/mission-menopause-my-hormones-went-off-a-cliff-and-im-not-going-to-be-ashamed"},{"key":"2025090510440365000_50.2.122.57","unstructured":"Grose J . Why is perimenopause still such a mystery? The New York Times; 2021. Available: https:\/\/www.nytimes.com\/2021\/04\/29\/well\/perimenopause-women.html(April 21)"},{"key":"2025090510440365000_50.2.122.58","unstructured":"Malone S , Weiss-Wolf J . America lost its way on menopause research, it\u2019s time to get back on track. The Washington Post; 2022. Available: https:\/\/www.washingtonpost.com\/opinions\/2022\/04\/28\/menopause-hormone-therapy-nih-went-wrong\/(April 28)"},{"key":"2025090510440365000_50.2.122.59","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3362"},{"key":"2025090510440365000_50.2.122.60","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2015.5556"},{"key":"2025090510440365000_50.2.122.61","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1080\/13697137.2022.2122792","article-title":"Brain fog in menopause: a health-care professional\u2019s guide for decision-making and counseling on cognition","volume":"25","author":"Maki","year":"2022","journal-title":"Climacteric"},{"key":"2025090510440365000_50.2.122.62","doi-asserted-by":"publisher","DOI":"10.1089\/152460901750269670"},{"key":"2025090510440365000_50.2.122.63","doi-asserted-by":"publisher","DOI":"10.1097\/00042192-200007040-00008"},{"key":"2025090510440365000_50.2.122.64","unstructured":"Phelps K . Menopause brain: the inability to think clearly is not \u2018all in your mind. The Guardian 2021. Available: https:\/\/www.theguardian.com\/society\/2021\/oct\/10\/menopause-brain-the-inability-to-think-clearly-is-not-all-in-your-mind(October 10, 2021)"},{"key":"2025090510440365000_50.2.122.65","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000277275.42504.93"},{"key":"2025090510440365000_50.2.122.66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001833","article-title":"Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, controlled KEEPS-cognitive and affective study","volume":"12","author":"Gleason","year":"2015","journal-title":"PLoS Med"},{"key":"2025090510440365000_50.2.122.67","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002980"},{"key":"2025090510440365000_50.2.122.68","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/GME.0b013e318287474f","article-title":"Continuous-combined oral estradiol\/drospirenone has no detrimental effect on cognitive performance and improves estrogen deficiency symptoms in early postmenopausal women: a randomized placebo-controlled trial","volume":"20","author":"Davison","year":"2013","journal-title":"Menopause"},{"key":"2025090510440365000_50.2.122.69","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/GME.0000000000001713","article-title":"#Menopause on Instagram: a mixed-methods study","volume":"28","author":"Arseneau","year":"2021","journal-title":"Menopause"},{"key":"2025090510440365000_50.2.122.70","doi-asserted-by":"crossref","first-page":"146","DOI":"10.5694\/mja14.01723","article-title":"Use of complementary and alternative medicines for menopausal symptoms in Australian women aged 40-65 years","volume":"203","author":"Gartoulla","year":"2015","journal-title":"Med J Aust"}],"container-title":["BMJ Sexual &amp; Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjsrh-2023-202099","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T18:08:11Z","timestamp":1757095691000},"score":1,"resource":{"primary":{"URL":"https:\/\/jfprhc.bmj.com\/lookup\/doi\/10.1136\/bmjsrh-2023-202099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,9]]},"references-count":70,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,4,11]]},"published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1136\/bmjsrh-2023-202099"],"URL":"https:\/\/doi.org\/10.1136\/bmjsrh-2023-202099","relation":{},"ISSN":["2515-1991","2515-2009"],"issn-type":[{"value":"2515-1991","type":"print"},{"value":"2515-2009","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,9]]}}}